Alain Ndayisaba

Iron in Neurodegeneration – Cause or Consequence?

G. Wenning, Alain Ndayisaba, Christine Kaindlstorfer, 2019, Front. Neurosci..

TNFα inhibitors as targets for protective therapies in MSA: a viewpoint

K. Jellinger, G. Wenning, T. Berger, 2019, Journal of Neuroinflammation.

Inhibition of the mammalian target or rapamycin (mTOR): a potential therapeutic strategy for multiple system atrophy

G. Wenning, Alain Ndayisaba, 2020, Clinical Autonomic Research.

Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-Phenotyping

Sonja W. Scholz, Derek H. Oakley, J. Schmahmann, 2022, Cerebellum.

Rapid iPSC inclusionopathy models shed light on formation, consequence and molecular subtype of -synuclein inclusions AUTHORS

S. Elledge, R. Jaenisch, I. Ferrer, 2022 .

Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions

S. Elledge, R. Jaenisch, I. Ferrer, 2022, Neuron.

TNFα inhibitors as targets for protective therapies in MSA: a viewpoint

K. Jellinger, G. Wenning, T. Berger, 2019, Journal of neuroinflammation.

Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges

G. Wenning, N. Stefanova, Alain Ndayisaba, 2019, Clinical Autonomic Research.